Navigation Links
New consensus on work-related asthma
Date:9/23/2008

In a new consensus statement, the American College of Chest Physicians offers guidance on the diagnosis and treatment of work-related asthma (WRA), a chronic respiratory condition that includes occupational asthma and work-exacerbated asthma (WEA) and affects as many as 25 percent of adults with asthma. Published as a supplement to the September issue of CHEST, the consensus statement, updated from 1995, places new emphasis on

  1. preventive measures, including better control of exposures;
  2. the need for a combination of diagnostic testing; and
  3. the importance of obtaining a full medical and occupational history in patients with suspected WRA.

The statement also places greater consideration on the diagnosis and management of WEA, which is preexisting or concurrent asthma that is worsened by work-related conditions. Developed by an expert panel of specialists in allergy, pulmonary medicine, and occupational medicine, the consensus statement provides supplemental materials, including a worker/workplace fact sheet and physician flow sheets to help physicians and other health-care providers diagnose and manage WRA. For more information related to the ACCP consensus statement on work-related asthma, visit www.chestjournal.org.


'/>"/>

Contact: Jennifer Stawarz
jstawarz@chestnet.org
847-498-8306
American College of Chest Physicians
Source:Eurekalert

0

GOOD

Page: 1

Related biology technology :

1. Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines
2. International Wound Care Experts, Medline Announce Pressure Ulcer Prevention Consensus Paper
3. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
4. New Patient Satisfaction Study With budesonide/formoterol Combination Therapy and fluticasone/salmeterol Combination Therapy in Adults With Asthma
5. Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows
6. Asthma Patients Not Adequately Controlled on ICS Alone More Likely to Benefit From Advair(R) Than Doubling the Dose of ICS
7. Apieron, Inc. Announces FDA Clearance of the Insight(TM) eNO System to Assist Physicians with Patient Asthma Management
8. Allergy Standards LTD to Attend 2008 American Academy of Allergy, Asthma and Immunology Conference
9. FDA Grants Market Clearance to Aerocrine Inc.s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma
10. Drug Reduces Airway Mucus in Preclinical Asthma Model
11. AIM-Quoted Verona Pharma Progresses Anti-Asthma Drug Studies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ollowing the provision of clinical,and scientific ... privately,owned UK company Daval International Li...en informed that its innovative,anti-inflammatory ...esignation for the treatment of Amyotrophic Latera...ou Gehrig,s disease, is the most common form of Mo...
(Date:11/6/2009)...Call/ -- BioSpecifics Technologies Corp. (Nasdaq: ...rst-in-class collagenase-based products, today ann... ended September 30, 2009. ,, "We were extreme...s Arthritis Advisory Committee unanimously recomme...M) for the treatment of Dupuytren,s disease, and w...
(Date:11/6/2009)...e/ -- Calbiotech, Inc. announced today that it has... (SBIR) Phase I contract by the U.S. Army Medical ...agreement, Calbiotech will develop analyte specifi...s. ,, Dengue virus is a mosquito-born flaviv...rces deployed to tropical areas of the world. Due ...
(Date:11/5/2009)...rstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) today an...r ended September 30, 2009. GenVec reported a net ...ee months ended September 30, 2009 compared to a n...omparable quarter of 2008. For the nine months end... million ($0.15 per share), compared to a net loss...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
..., , , , Martin Simon, Petra Albrec..., Martin Simon, Petra Albrecht, and Helmut ... Germany, Department of Ecology , Andrs Jar... , With the help of the Eppendorf cMaste... expression of Paramecium primaurelia individual c...
..., , , , George Halley and Vincent ...5 Prime, Inc., Boulder, CO, USA , Vincent P...ion Lab, Westbury, , NY , , ...ve become very popular because of their convenienc...ic amplification. Typical Hot Start , enz...
..., , , , Abstract , , ...ws researchers to determine , the presence,...script in , the organism, tissue or cell of... synthesis of a cDNA copy of all the mRNA present... of the gene(s) of interest. Due to buffer incompa...
Other Biology Technology:Single-cell RT-PCR Analysis of Paramecium Primaurelia with the Eppendorf , cMaster RTplusPCR System 2Single-cell RT-PCR Analysis of Paramecium Primaurelia with the Eppendorf , cMaster RTplusPCR System 3Single-cell RT-PCR Analysis of Paramecium Primaurelia with the Eppendorf , cMaster RTplusPCR System 4Single-cell RT-PCR Analysis of Paramecium Primaurelia with the Eppendorf , cMaster RTplusPCR System 5Single-cell RT-PCR Analysis of Paramecium Primaurelia with the Eppendorf , cMaster RTplusPCR System 6Single-cell RT-PCR Analysis of Paramecium Primaurelia with the Eppendorf , cMaster RTplusPCR System 7HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 2HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 3HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 4HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 5HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 6HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 7cMaster RTplusPCR System for increased sensitivity and product length , in RT-PCR 2cMaster RTplusPCR System for increased sensitivity and product length , in RT-PCR 3cMaster RTplusPCR System for increased sensitivity and product length , in RT-PCR 4cMaster RTplusPCR System for increased sensitivity and product length , in RT-PCR 5cMaster RTplusPCR System for increased sensitivity and product length , in RT-PCR 6
(Date:11/8/2009)...loss of a gene through deletion of genetic materia...abnormalities in learning and behavior, said a con...dicine ( www.bcm.edu ) in a report that appears on...This research goes about 95 percent of the way to ...viduals to this gene," said Dr. Arthur L. Beaudet ...
(Date:11/6/2009)... in harmony with their arboreal hosts. But new res...their trees of choice, the ants can get destructiv...d in the November issue of the American Naturalis...ive trees, and it reopens a centuries-old debate o...ts and certain species of plants and trees have co...
(Date:11/5/2009)...le University have developed synthetic molecules c...HIV and HIV-infected cells, as well as to prostate... the Journal of the American Chemical Society , c...e diseases. , The molecules called "antibody-r...ibody-recruiting molecule targeting prostate cance...
Breaking Biology News(10 mins):Developmental delay could stem from nicotinic receptor deletion 2Ants are friendly to some trees, but not others 2New synthetic molecules trigger immune response to HIV and prostate cancer 21 in 6 health workers wont report in flu pandemic study by Ben Gurion U researchers 9397 11 in 6 health workers wont report in flu pandemic study by Ben Gurion U researchers 9397 21 in 6 health workers wont report in flu pandemic study by Ben Gurion U researchers 9397 3Wildfires set to increase 50 percent by 2050 9392 1Wildfires set to increase 50 percent by 2050 9392 2More Can Be Done to Slow Obesitys Toll on Health 3A Experts 52960 1More Can Be Done to Slow Obesitys Toll on Health 3A Experts 52960 2More Can Be Done to Slow Obesitys Toll on Health 3A Experts 52960 3More Can Be Done to Slow Obesitys Toll on Health 3A Experts 52960 4
...ing plastic waste, discarded lead-acid batteries a...ed attack under a new agreement signed by the Unit...al treaty body controlling hazardous wastes. The M...irobi, Kenya, by the UN Environment Programme (UNE...the Basel Convention on the Control of Transbounda...
...gene they suspect plays an important role in trigg...rops a century-and-a-half ago. , And the pathogen...nts of agricultural damage throughout the modern w.... , The scientists describe the gene, called Avr3...tion of the Proceedings of the National Academy of...
...oute of drug administration to improve patient com... skin patches are rapidly becoming an important he...arket share for the treatment of chronic condition...logy is set to make further inroads as transdermal...ay through the development and clinical trial proc...
Other Biology News:Researchers find gene that may be at root of potato blight 2Researchers find gene that may be at root of potato blight 3
Chaperone Sampler Kit from BD Biosciences Pharmingen
SH3 Proteins II Sampler Kit from BD Biosciences Pharmingen
Mouse Anti-SOCS3 Monoclonal Antibody, Unconjugated, Clone SOC-25 from BioLegend
Caveolin Sampler Kit from BD Biosciences Pharmingen
Biology Products: